Frazier Life Sciences (investor - Private Equity)
See something wrong or missing? Let us know
Offices:San Francisco
Frazier Life Sciences is an American healthcare investment firm focusing on companies developing novel therapeutics from company formation to scale.
Average round investment:192.18m USD
Average number per year:1.33
Portfolio companies:
Immutrin
Tubulis
Alentis Therapeutics
See the entire list
Immutrin
Tubulis
Alentis Therapeutics
See the entire list
Mostly invests in:
Germany (2)
Health services (4)
Germany (2)
Health services (4)
Investments
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Belgium
Netherlands
Austria
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain